ClinConnect ClinConnect Logo
Search / Trial NCT06979570

Personalized Performance Optimization Platform

Launched by MASSACHUSETTS GENERAL HOSPITAL · May 13, 2025

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Long Duration Spaceflight Cogntiive Performance Wearable Biosensors Closed Loop Systems Auditory Stimulation Haptic Feedback Light Modulation Psychophysiological Monitoring Sensorimotor Performance Behavioral Health Management Attention Optimization Stress Reduction Fatigue Management Cognitive Load Environmental Modulations Performance Enhancement Non Invasive Sensors Adaptive Techology Personalized Feedback

ClinConnect Summary

The "Personalized Performance Optimization Platform" trial is studying how to help astronauts perform their best during long space missions, like those to the Moon or Mars. These missions can be tough due to stressors like lack of sleep, limited social interaction, and communication delays with support teams back on Earth. To tackle these challenges, researchers at Massachusetts General Hospital and the Massachusetts Institute of Technology are developing a new technology that can adapt the working environment onboard based on real-time feedback from sensors monitoring the astronauts' health and performance.

If you're between the ages of 18 and 64, have normal or corrected vision and hearing, and are willing to participate, you may be eligible for this study. Participants will need to be able to sit still and stay awake during the sessions. It’s important to know that those with neurological or psychiatric disorders cannot join, and if you've already participated in a related study, you won't be eligible due to the specific learning involved in the tests. By joining this study, you’ll be contributing to crucial research that aims to enhance the well-being and performance of future space explorers.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Willingness to participate in the study
  • Must be between the ages of 18 to 64
  • Normal or corrected-to-normal vision and hearing
  • Ability to sit still and stay awake during the experimental sessions
  • Exclusion Criteria:
  • Diagnosis with Neurological or psychiatric disorder
  • Participation in a prior study associated with this protocol (due to the learning- curve on some of the behavioral tests)

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Cambridge, Massachusetts, United States

Charlestown, Massachusetts, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported